img

China says Japanese flu drug is 'clearly effective' in treating coronavirus

Chinese medical authorities have brought attention to a drug in Japan used for new influenza strains that seems to be effective in fighting coronavirus.

ADVERTISEMENT
Image
Sam Edwards High Level Alberta
ADVERTISEMENT

Chinese medical authorities have brought attention to a drug in Japan that is used for new influenza strains and seems to be effective in fighting coronavirus according to The Guardian.

An official named Zhang Xinmin from China’s science and technology ministry noted that favipiravir showed positive outcomes during clinical trials with 340 patients in Shenzhen and Wuhan. Favipiravir was made by a Fujifilm subsidiary company.

“It has a high degree of safety and is clearly effective in treatment,” Zhang said to reporters on Tuesday.

In a median of four days after they became positive with the virus—patients who received the medicine became negative, compared with an 11 day median for people who did not receive the drug, according to public broadcaster NHK.

X-rays also showed improvements in the lung condition of around 91 percent of patients who were given Favipiravir, as opposed to 62 percent of people who did not use the drug.

In Japan, doctors are using the drug in clinical studies on patients who have mild symptoms of coronavirus.

A source from the Japanese health ministry noted that the drug—also known as Avigan—has not been as effective for people experiencing severe symptoms.

“We’ve given Avigan to 70 to 80 people, but it doesn’t seem to work that well when the virus has already multiplied,” the source said when talking to Mainichi Shimbun.

Favipiravir was supplied by the Japanese government as an emergency measure to treat the Ebola virus outbreak in 2016.

The drug would require government approval before it could be used for coronavirus patients on a large scale because its original use was to treat flu.

When speaking with the Mainichi, a health official noted that the drug could see approval as soon as May. “But if the results of clinical research are delayed, approval could also be delayed.”

ADVERTISEMENT
ADVERTISEMENT

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2024 The Post Millennial, Privacy Policy | Do Not Sell My Personal Information